Protalix Biotherapeutics
Total Raised
$6.3MInvestors Count
6Deal Terms
1Funding, Valuation & Revenue
4 Fundings
Protalix Biotherapeutics has raised $6.3M over 4 rounds.
Protalix Biotherapeutics's latest funding round was a PIPE for $40M on February 18, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/18/2021 | PIPE | $40M | Undisclosed Investors | 2 | ||
8/22/2006 | Reverse Merger | |||||
8/18/2005 | Series C | |||||
3/28/2005 | Series B |
Date | 2/18/2021 | 8/22/2006 | 8/18/2005 | 3/28/2005 |
|---|---|---|---|---|
Round | PIPE | Reverse Merger | Series C | Series B |
Amount | $40M | |||
Investors | Undisclosed Investors | |||
Valuation | ||||
Revenue | ||||
Sources | 2 |
Protalix Biotherapeutics Deal Terms
1 Deal Term
Protalix Biotherapeutics's deal structure is available for 1 funding round, including their Series B from March 28, 2005.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Protalix Biotherapeutics Investors
6 Investors
Protalix Biotherapeutics has 6 investors. Orthodontix invested in Protalix Biotherapeutics's Reverse Merger funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/22/2006 | 8/22/2006 | 1 Reverse Merger | Holding Company | Florida | ||
Private Equity | Liechtenstein | |||||
Venture Capital | Israel | |||||
Asset/Investment Management | Colorado | |||||
Venture Capital | Israel |
First funding | 8/22/2006 | ||||
|---|---|---|---|---|---|
Last Funding | 8/22/2006 | ||||
Investor | |||||
Rounds | 1 Reverse Merger | ||||
Board Seats | |||||
Type | Holding Company | Private Equity | Venture Capital | Asset/Investment Management | Venture Capital |
Location | Florida | Liechtenstein | Israel | Colorado | Israel |
Loading...